Joan Cox Gill

5.9k citations

121 papers · 3.9k indexed · h-index 38

Hematology top 0.2%
Surgery top 5%
Genetics top 2%
Immunology top 5%
Cardiology and Cardiovascular Medicine top 5%

Co-authors: Robert R. Montgomery Sandra L. Haberichter Veronica H. Flood Pamela A. Christopherson Kenneth D. Friedman Amy D. Shapiro Patricia A. Morateck J. Michael Soucie
Topics: Platelet Disorders and Treatments (80 papers)Hemophilia Treatment and Research (40 papers)Blood groups and transfusion (38 papers)
Cited by: Hematology Internal Medicine Genetics
Journals: New England Journal of Medicine Journal of Clinical InvestigationSHILAP Revista de lepidopterología
Partner nations: United States Canada Germany

In The Last Decade

Joan Cox Gill

118 papers receiving 3.7k citations

Peers

Countries citing papers authored by Joan Cox Gill

Since Specialization

Citations

This map shows the geographic impact of Joan Cox Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Cox Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Cox Gill more than expected).

Fields of papers citing papers by Joan Cox Gill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Cox Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Cox Gill. The network helps show where Joan Cox Gill may publish in the future.

Co-authorship network of co-authors of Joan Cox Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Cox Gill. A scholar is included among the top collaborators of Joan Cox Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Cox Gill. Joan Cox Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease 2019 ·American Journal of Hematology ·Karon Abe,(unknown),Sarah H. O’Brien,(unknown),Roshni Kulkarni,Joan Cox Gill,Vanessa R. Byams,(unknown)	15
2	Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD 2017 ·Blood ·Sandra L. Haberichter,Pamela A. Christopherson,Veronica H. Flood,Joan Cox Gill,Kenneth D. Friedman,Robert R. Montgomery	2
3	Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD 2017 ·Blood ·Jéssica Leite Garcia,Pamela A. Christopherson,Veronica H. Flood,Joan Cox Gill,Robert R. Montgomery,Paula D. James,Pippa Simpson,Liyun Zhang,Thomas C. Abshire,(unknown)	2
4	Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program 2017 ·Blood ·Pamela A. Christopherson,(unknown),Daniel B. Bellissimo,Veronica H. Flood,Joan Cox Gill,Sandra L. Haberichter,Robert R. Montgomery,(unknown)	3
5	Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease 2015 ·Blood ·Joan Cox Gill,Giancarlo Castaman,Jerzy Windyga,Peter A. Kouides,Margaret V. Ragni,Frank W.G. Leebeek,(unknown),(unknown),Sandor Fritsch,Borislava G. Pavlova,(unknown),Bruce M. Ewenstein	104
6	Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening 2015 ·American Journal of Hematology ·Connie H. Miller,(unknown),Brian Boylan,Amanda B. Payne,F. M. Kelly,Miguel A. Escobar,Joan Cox Gill,Cindy Leissinger,J. Michael Soucie	7
7	Spectrum of Type 2 Von Willebrand Disease in the Zimmerman Program 2014 ·Blood ·Veronica H. Flood,Pamela A. Christopherson,Daniel B. Bellissimo,Joan Cox Gill,Sandra L. Haberichter,Kenneth D. Friedman,Rupa Udani,Jonathan Roberts,Robert R. Montgomery,(unknown)	2
8	Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial 2013 ·Blood ·Pier Mannuccio Mannucci,Christine L. Kempton,Carolyn M. Millar,Edward H. Romond,Amy D. Shapiro,Ingvild Birschmann,Margaret V. Ragni,Joan Cox Gill,T. T. Yee,Robert Klamroth,Wing-Yen Wong,(unknown),Werner Engl,Peter L. Turecek,(unknown),Bruce M. Ewenstein	87
9	The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia 2013 ·British Journal of Haematology ·Sweta Gupta,Azfar-e-Alam Siddiqi,J. Michael Soucie,Marilyn J. Manco‐Johnson,Roshni Kulkarni,(unknown),(unknown),Joan Cox Gill	20
10	Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo 2012 ·Journal of Thrombosis and Haemostasis ·Qizhen Shi,Erin L. Kuether,Jocelyn A. Schroeder,(unknown),Scot A. Fahs,Joan Cox Gill,Robert R. Montgomery	20
11	Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres 2011 ·Haemophilia ·Vanessa R. Byams,Peter A. Kouides,(unknown),Judith Baker,Deborah Brown,Joan Cox Gill,Althea M. Grant,Allison James,Barbara A. Konkle,Jennifer Maahs,(unknown),(unknown),(unknown),Diane J. Nugent,Claire S. Philipp,J. Michael Soucie,(unknown)	57
12	Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A 2005 ·Thrombosis and Haemostasis ·Joan Cox Gill,Chantal Rothschild,Marilyn J. Manco‐Johnson,(unknown),(unknown),Eduard Gorina,Peter J. Larson,W. Kreuz,(unknown)	79
13	Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate‐P^®): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy 2003 ·Haemophilia ·Joan Cox Gill,Bruce M. Ewenstein,Arthur R. Thompson,Guenther Mueller‐Velten,Bruce A. Schwartz,(unknown)	55
14	Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study 2003 ·Journal of Thrombosis and Haemostasis ·Guy Young,Marilyn J. Manco‐Johnson,Joan Cox Gill,Donna DiMichele,Michael D. Tarantino,Thomas C. Abshire,Diane J. Nugent	31
15	Pneumocystis carinii Pneumonia in Patients With Diamond-Blackfan Anemia Receiving High-Dose Corticosteroids 2002 ·Journal of Pediatric Hematology/Oncology ·Winston W. Huh,Joan Cox Gill,Sujit Sheth,George R. Buchanan	8
16	Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection 2000 ·Immunological Reviews ·David D. Eckels,Huiru Wang,(unknown),Niloofar M. Tabatabai,Joan Cox Gill	84
17	Interferon‐γ secretion defects in haemophilia A patients receiving highly purified plasma‐derived or recombinant factor VIII 1996 ·British Journal of Haematology ·(unknown),David J. Tollerud,(unknown),Joan Cox Gill	3
18	Hepatitis C virus: models of immunopathogenesis and prophylaxis 1996 ·Transfusion ·David D. Eckels,Phyllis Flomenberg,Joan Cox Gill	12
19	Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association. 1995 ·Journal of Clinical Investigation ·David A. Wilcox,Cathy Paddock,Suzanne Lyman,Joan Cox Gill,Peter J. Newman	60
20	Inherited absence of OKT4 lymphocyte antigen in a chronically transfused patient with homozygous sickle cell disease 1985 ·The Journal of Pediatrics ·Joan Cox Gill,(unknown),Afzal Nikaein,Phyllis A. Kirchner,(unknown),(unknown),Robert R. Montgomery,James T. Casper	1

About Joan Cox Gill

Joan Cox Gill is a scholar working on Hematology, Genetics and Internal Medicine, having authored 121 papers that have together received 3.9k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (80 papers), Hemophilia Treatment and Research (40 papers) and Blood groups and transfusion (38 papers). The work is most often cited by research in Hematology (3.1k citations), Internal Medicine (210 citations) and Genetics (555 citations). Joan Cox Gill has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Robert R. Montgomery, Sandra L. Haberichter, Veronica H. Flood, Pamela A. Christopherson, Kenneth D. Friedman, Amy D. Shapiro, Patricia A. Morateck, J. Michael Soucie, Cindy Leissinger and Craig M. Kessler. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact